These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

83 related articles for article (PubMed ID: 7482392)

  • 1. [The future of pharmacological models].
    Bourin M
    Therapie; 1995; 50(4):375-9. PubMed ID: 7482392
    [TBL] [Abstract][Full Text] [Related]  

  • 2. [Development of antituberculous drugs: current status and future prospects].
    Tomioka H; Namba K
    Kekkaku; 2006 Dec; 81(12):753-74. PubMed ID: 17240921
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Considerations for the sensible use of rodent models of inflammatory disease in predicting efficacy of new biological therapeutics in the clinic.
    Arnett HA; Viney JL
    Adv Drug Deliv Rev; 2007 Sep; 59(11):1084-92. PubMed ID: 17804112
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [Genetically modified animals as models for psychiatric diseases].
    Sora I; Kobayashi H; Numachi Y
    Seishin Shinkeigaku Zasshi; 2005; 107(3):285-9. PubMed ID: 15856753
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The ultimate model organism: progress in experimental medicine.
    Littman BH; Williams SA
    Nat Rev Drug Discov; 2005 Aug; 4(8):631-8. PubMed ID: 16056389
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Drug research: from the idea to the product.
    Kuhlmann J
    Int J Clin Pharmacol Ther; 1997 Dec; 35(12):541-52. PubMed ID: 9455711
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Practical development of genetically engineered animals as human disease models.
    Nomura T
    Lab Anim Sci; 1997 Apr; 47(2):113-7. PubMed ID: 9150486
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Responsibilities of clinical pharmacology in the early phase of drug development].
    Kuhlmann J
    Med Klin (Munich); 2000 May; 95(1 Spec No):31-40. PubMed ID: 10851846
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Animal models of obsessive-compulsive disorder: rationale to understanding psychobiology and pharmacology.
    Korff S; Harvey BH
    Psychiatr Clin North Am; 2006 Jun; 29(2):371-90. PubMed ID: 16650714
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Testing human biologicals in animal host resistance models.
    Burleson GR; Burleson FG
    J Immunotoxicol; 2008 Jan; 5(1):23-31. PubMed ID: 18382855
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Alternative strategies in drug development: clinical pharmacological aspects.
    Kuhlmann J
    Int J Clin Pharmacol Ther; 1999 Dec; 37(12):575-83. PubMed ID: 10599949
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Therapeutic strategies and Alzheimer's disease: contribution of animal models].
    Chabrier PE
    Ann Pharm Fr; 2009 Mar; 67(2):97-103. PubMed ID: 19298893
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The use of animal models in cancer drug discovery and development.
    Curt GA
    Stem Cells; 1994 Jan; 12(1):23-9. PubMed ID: 8142918
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Animal models of bipolar disorder.
    Kato T; Kubota M; Kasahara T
    Neurosci Biobehav Rev; 2007; 31(6):832-42. PubMed ID: 17466374
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Clinical predictive value of the in vitro cell line, human xenograft, and mouse allograft preclinical cancer models.
    Voskoglou-Nomikos T; Pater JL; Seymour L
    Clin Cancer Res; 2003 Sep; 9(11):4227-39. PubMed ID: 14519650
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Candidate genes for panic disorder: insight from human and mouse genetic studies.
    Gratacòs M; Sahún I; Gallego X; Amador-Arjona A; Estivill X; Dierssen M
    Genes Brain Behav; 2007 Jun; 6 Suppl 1():2-23. PubMed ID: 17543035
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The utility of animal models in the preclinical study of interventions to prevent human coronary artery restenosis: analysis and recommendations. On behalf of the Subcommittee on Animal, Cellular and Molecular Models of Thrombosis and Haemostasis of the Scientific and Standardization Committee of the International Society on Thrombosis and Haemostasis.
    Johnson GJ; Griggs TR; Badimon L
    Thromb Haemost; 1999 May; 81(5):835-43. PubMed ID: 10365761
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Utility of animal models for identification of potential therapeutics for rheumatoid arthritis.
    Hegen M; Keith JC; Collins M; Nickerson-Nutter CL
    Ann Rheum Dis; 2008 Nov; 67(11):1505-15. PubMed ID: 18055474
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Preclinical restenosis models and drug-eluting stents: still important, still much to learn.
    Schwartz RS; Chronos NA; Virmani R
    J Am Coll Cardiol; 2004 Oct; 44(7):1373-85. PubMed ID: 15464316
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Genetically engineered models have advantages over xenografts for preclinical studies.
    Becher OJ; Holland EC
    Cancer Res; 2006 Apr; 66(7):3355-8, discussion 3358-9. PubMed ID: 16585152
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.